The catch, however, is that the product will be sold only in Israel, where pharmaceutical company Teva Pharm signed an agreement to market a medical marijuana inhaler previously used in a hospital, Reuters reported. The company said this is the first
Updated: 11/28/2016 02:26P
WASHINGTON — A panel of federal health experts is overwhelmingly recommending approval for a long-acting inhaler to treat people suffering from chronic lung disease. The Food and Drug Administration panel voted 15 to one that Boehringer Ingelheims
Updated: 01/29/2013 04:01P